HomeNews

News
New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

Global health
Malaria
Vaccines
Revolutionising Rural Vaccination: Ground-breaking Research Unveils Cost-Effective Model to Boost COVID-19 Immunisation in Developing Countries

Ground-breaking research unveils cost-effective model to boost COVID-19 immunisation in developing countries

COVID-19 vaccine
Global health
Health
Innovation
Medical Sciences
Research
Vaccines
New Phase 3 Trial Data Confirm the Uniquely High Efficacy and Good Safety Profile of the R21/Matrix-M Malaria Vaccine in African Children

New phase 3 trial data confirm the uniquely high efficacy and good safety profile of the R21/Matrix-M malaria vaccine in African children

Global health
Health
Malaria
Research
Vaccines
FCDO Minister meets with University of Oxford’s vaccine researchers

FCDO Minister meets with University of Oxford’s vaccine researchers

COVID-19 vaccine
Funding
Global health
Malaria
Research
Vaccines
Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

COVID-19 vaccine
Global health
Health
Vaccines
Long function machine for the Novel inhaled TB vaccine

Novel inhaled TB vaccine

Global health
Research
Vaccines
First-in-human vaccine trial for deadly Nipah virus launched

First-in-human vaccine trial for deadly Nipah virus launched

Global health
Vaccines
Oxford Vaccine Group, Department of Paediatrics, University of Oxford receives £7.8 million in research funding to fight pandemic and epidemic threats

Oxford Vaccine Group, Department of Paediatrics, University of Oxford receives £7.8 million in research funding to fight pandemic and epidemic threats

Funding
Vaccines
The Oxford Colloquy – New podcast series by Prof Sir Andrew Pollard

The Oxford Colloquy – New podcast series by Prof Sir Andrew Pollard

COVID-19 vaccine
Health
Vaccines
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

Vaccines

Pages